logo

PGHL vs VINEETLAB: Stock Comparison

PROCTER & GAMBLE HEALTH L vs VINEET LABORATORIESUpdated 22 Oct 26, 4:08 PM ISTNSE & company filings

PROCTER & GAMBLE HEALTH L is the larger company by market capitalisation. PROCTER & GAMBLE HEALTH L shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

PGHL leads 9; VINEETLAB leads 0 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

PGHLVINEETLAB

Valuation lens

What price are you paying?

Market CapContext only
₹8,398 Cr
₹71 Cr
P/E RatioSame reading
23.53x
—
P/B RatioSame reading
16.01x
—
EPSPGHL has the higher reading
₹57.92 ✓
₹0.63
Book ValueContext only
₹316.01
₹23.74
Dividend YieldPGHL has the higher reading
2.77% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
PGHL is the larger company
₹8,398 Cr vs ₹71 Cr
EPS
PGHL has higher earnings per share
₹57.92 vs ₹0.63
Dividend Yield
PGHL has a higher dividend yield
2.77% vs 0%
Revenue Growth (TTM YoY)
PGHL has faster revenue growth
19.1% vs 11.05%
EPS Growth (TTM YoY)
PGHL has faster EPS growth
54.6% vs 0%
ROE
PGHL has a higher ROE
62.32% vs -69.22%
ROCE
PGHL has a higher ROCE
92.1% vs -11.29%
Net Margin
PGHL has a higher net margin
23.22% vs -26.92%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricPGHLVINEETLAB
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricPGHLVINEETLAB
Live Price₹5,062.5₹37.19
Day Change0.29%-2.18%
Volume8,36456,953
52-Week High₹6,975₹49.99
52-Week Low₹4,707₹27.96
Distance from 52W High-27.42%-25.61%

Valuation

MetricPGHLVINEETLAB
Market Cap₹8,398 Cr₹71 Cr
P/E Ratio23.53x—
P/B Ratio16.01x—
EPS₹57.92₹0.63
Book Value₹316.01₹23.74
Dividend Yield2.77%0%

Growth

MetricPGHLVINEETLAB
Revenue Growth (TTM YoY)19.1%11.05%
EPS Growth (TTM YoY)54.6%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricPGHLVINEETLAB
ROE62.32%-69.22%
ROCE92.1%-11.29%
Net Margin23.22%-26.92%
Operating Margin31.99%-11.25%
Debt to Equity0x2.73x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricPGHLVINEETLAB
Promoter Holding0%5.98%
FII Holding6.42%▲ 0.09 pp0.5%▲ 0.14 pp
DII Holding12.63%▲ 0.19 pp—
Public Holding29.13%▼ 0.29 pp93.52%▼ 0.14 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: PROCTER & GAMBLE HEALTH L and VINEET LABORATORIES.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.